Hyaluronic Acid Viscosupplementation are anticipated to grow at a value CAGR of ~x% over 2019-2028. According to a study published by Insure Insights on the Hyaluronic Acid Viscosupplementation market is anticipated to gain popularity in the forecast period. The key factor propelling the industry includes, the growth in the diminishing lifestyles, which includes physical inactivity and the reduction of synovial fluid is anticipated to boost in the coming years. The growth in the healthcare spending would help the industry flourish in the near future.

Top Driver: Increase In the Awareness Programs to propel the industry

Hyaluronic Acid Viscosupplementation has rich demand in the developed and developing countries in the forecast period. This owes to the increase in the awareness programs by the various public-private organization and the government regarding the quality of life to be improves and hence is anticipated to help the industry grow in the coming years. The surge in the advancement of the products in period would also help the industry gain highest revenue shares in the near future. There is a growth in demand for minimally invasive surgical procedures which would help the industry gain higher revenue in the near future.

Hospitals to Make Crucial Contribution to Growth of Global Hyaluronic Acid Viscosupplementation Market

Among end user segments of the global Hyaluronic Acid Viscosupplementation market, hospitals are predicted to show significant growth in future. The hospitals have higher number of patient flow which would contribute to the growth of the industry during the forecast period. Furthermore, the rise in the investments over the research and development coupled with the increase in adoption of newer technologies would help the industry flourish in the coming years. The orthopedic Clinics would gain highest revenue due to increase in focus over the advanced technologies and hence would grow in the next few years.

Rising Investments to Benefit North America Market

North American countries such as the US are predicted to maximize their spending on technologies in future. This would contribute to the lucrative growth of the industry in the next few years. Furthermore, the rise in the investments on the research and development on the advancement of technologies would help the industry boost in the coming years. The surge in the disposable income of the population in the region is expected to help the industry flourish in the coming years. Asia Pacific region is also expected to grow due to the surge in population coupled with the surge in healthcare spending in the region.

Players to Focus on Hyaluronic Acid Viscosupplementation

The global Hyaluronic Acid Viscosupplementation market is expected to stay fragmented with the increase in the number of new entrants in the coming years. Anika Therapeutics, Bioventus, SynviscOne, Supartz, Q-Med, Stanford Chemicals, Carbylan Therapeutics, Croma-Pharma, Meda Pharma, TRB Chemedica, Swiss biomed Orthopaedics.

Anika Therapeutics: In 2014, Anika Therapeutics had received approval for its product MONOVISC. This is a single-injection type of hyaluronic acid viscosupplementation. Furthermore, another single-injection product CINGAL, from the same company was added in the pipeline, which is anticipated to fuel market growth in the coming years.

Zimmer Biomet: In November 2016, Zimmer Biomet had signed an exclusive distribution agreement with Seikagaku Corporation for the sales of VISCO-3 in the U.S. market. Zimmer Biomet also distributes Seikagaku Corporation’s Gel-One Cross-linked Hyaluronate product. This is anticipated to help the industry gain highest revenue shares in the forecast period.

Bioventus LLC: In February 2018, Bioventus LLC entered into an extension of its agreement with Seikagaku Corporation to continue the distribution and marketing of SUPARTZ FX in the U.S. This would help the players gain attention in the industry and hence propel the growth in the next few years.

Scope of the Report

By Type

• Standard
• Stabilized

By Application

• Hip Arthritis
• Ankle Arthritis
• Knee Arthritis
• Shoulder Arthritis

By End-User

• Hospitals
• Orthopedic Clinics
• Ambulatory Care Centers
• Others

By Region

• North America
• Europe
• Asia Pacific
• SAMEA

Key Reasons to Purchase this Report

1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.